CABG better than PCI for diabetes heart patients

Despite a rise in the use of drug-eluting stents, coronary bypass surgery is still the best bet for diabetes patients with multi-vessel disease, an Australian meta-analysis finds.

Diabetes patients undergoing coronary artery bypass grafting (CABG) for multi-vessel disease were 38% less likely to have died within three years compared with those who had had a percutaneous coronary intervention with a drug-eluting stent (PCI-DES),